ProtoLytic, LLC

ProtoLytic, LLC is a biotechnology, health care, and information technology company founded in 1999 and headquartered in the United States. The company's slogan "ProtoLytic has automated the evidence-based decision support system, to reduce time to quality care" encapsulates their focus on advancing the healthcare sector. ProtoLytic's core engine correlates diagnosis with associated medical procedures, products, and drugs using evidence-based guidelines. Its algorithms create a probability distribution for each diagnosis code and patient. The system can be integrated into billing or claims platforms or accessed through the ProtoLytic Client Portal, offering versatility to clients. In March 2022, ProtoLytic secured a $1.41M Venture Round investment, indicative of investor confidence in its innovative approach to healthcare decision support.